Abstract:OBJECTIVE:To investigate the changes of plasma hydrogen sulfide (H(2)S) in patients with coronary heart disease (CHD). METHODS:Plasma H(2)S levels were measured in 40 patients with CHD and 17 angiographically normal patients by sulfide-sensitive electrodes, and the variation of plasma H(2)S levels was analyzed in different clinical types of CHD and in different types of coronary artery lesions. The association of plasma H(2)S levels with the risk factors of CHD was also analyzed. RESULTS:Plasma H(2)S levels were significantly lowered in CHD patients in comparison with that in angiographically normal control subjects (26.10+/-14.27 micromol/L vs 51.74+/-11.94 micromol/L, P<0.001). In CHD patients, plasma H(2)S levels in unstable angina patients (UAP, 23.60+/-14.41 micromol/L) and acute myocardial infarction patients (AMI, 19.98+/-7.516 micromol/L) were significantly lower than that in stable angina patients (SAP, 38.41+/-14.53 micromol/L, P<0.05). No significant difference in plasma H(2)S levels was found between CHD patients with double-vessel and multi-vessel lesions (16.91+/-7.98 vs 18.39+/-7.78 micromol/L, P>0.05), but the two groups of patients had significantly lower plasma H(2)S levels than patients with single-vessel involvement (33.04+/-15.01 micromol/L, P<0.05 and P<0.01, respectively). Plasma H(2)S level was significantly lower in CHD patients with coronary artery occlusion than in patients with simple stenosis (19.04+/-9.55 vs 28.24+/-14.85 micromol/L, P<0.05). Among the CHD patients, H(2)S levels were significantly lower in smokers than in non-smokers (27.54+/-10.37 vs 32.24+/-15.77 micromol/L, P<0.05), also lower in hypertensive patients than in normotensive patients (20.36+/-8.69 vs 33.77+/-15.86 micromol/L, P<0.01). Plasma H(2)S levels showed a significant inverse correlation with blood glucose (r=-0.493 6, P=0.001 6), but there were no significant correlations with sex, age, cholesterol, triglyeride, TC, low-density lipoprotein, high-density lipoprotein, or body mass index. CONCLUSION:Decreased plasma H(2)S levels may correlate with the severity of CHD and changes of the coronary artery, and may implicate the risk factors of CHD such as smoking, hypertension, and high blood glucose.

Changes of Plasma Levels of Soluble VEGFR2 and SOD in Hypertensive Patients and Hypertensive Diabetic Patients

GW26-e0802 Decreased Soluble VEGFR2 and Increased Visfatin Expressions in Hypertensive and Hypertensive Diabetic Patients

Changes of plasma soluble endothelial cell protein C receptor and thrombomodulin levels in patients with type 2 diabetes mellitus

Effects of Plasma Hydrogen Sulfide and Nitric Oxide in Hypertensive Patients

Changes of Endothelium Dependent Vasodilatation in Patients with Hypertension and Impaired Glucose Tolerance

Changes of Coagulation and Fibrinolytic Function in Elderly Patients with Essential Hypertension and Diabetes

Study of superoxide dismutase and malondialdehyde contents in hypertensive patients at high altitude

Clinical research of vascular endothelial function change in type 2 diabetes patients

[Relationship Between Angiopoietin-2 and Vascular Endothelial Factor and Vasodilation Function in Hypertensive Patients].

[Plasma Hydrogen Sulfide and Homocysteine Levels in Hypertensive Patients with Different Blood Pressure Levels and Complications].

The Association Between Hypertensive Complications and Serum Levels of Soluble CD40/CD40L in Patients with Cardiovascular Diseases

Serum soluble tumor necrosis factor receptor levels in T2DM patients with early diabetic kidney disease and the clinical implications

The Relationship Between Hydrogen Sulfide Plasmas and Essential Hypertensive in Han Chinese Patients

[Changes of the New Gaseous Transmitter H2S in Patients with Coronary Heart Disease].

The relationship of superoxide dismutase and malondialdehyde levels with left ventricular geometry and function in patients with primary hypertension

The Relationship Between Diabetes with Hypertension and Changes of Plasma Endothelin(ET) and Calcitonin Gene Related Peptide(CGRP)

The Relativity Study Between Soluble E-selectin and Soluble Vascular Cell Adhesion Molecule-1 and Diabetic Retinopathy

Changes and clinical significance of serum level of angiopoietin-2 in T2DM patients

The Changes of Urinary Vascular Endothelial Growth Factor Excretion and Its Clinical Sig Nificance in Type 2 Diabetes Mellitus

Changes of Plasma Ghrelin Levels and Relevant Factors in Essential Hypertensive Patients

The effect of nephropathy on plasma sphingosine 1-phosphate concentrations in patients with type 2 diabetes